Institutional Ownership Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). We have compiled data on the 166 institutions that hold shares in the stock, with a total of 120 Million shares, which have been reported (via 13F filing form) to have a value of $377 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
27,525,640
shares
|
$83.4 Million
0.89% of portfolio
|
Q1 2024
Added 20.15%
|
|
Baillie Gifford & CO
|
Jan 31, 2025 Q4 2024 |
12,236,465
shares
|
$37.1 Million
0.03% of portfolio
|
Q4 2024
Reduced 5.1%
|
|
Voya Investment Management LLC
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
10,624,185
shares
|
$32.2 Million
0.04% of portfolio
|
Q2 2023
Reduced 1.97%
|
|
Capital World Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
7,933,613
shares
|
$24 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Prosight Management, LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
7,350,000
shares
|
$22.3 Million
6.4% of portfolio
|
Q4 2024
Reduced 19.05%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
4,547,315
shares
|
$13.8 Million
0.02% of portfolio
|
Q1 2024
Reduced 0.68%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
4,500,000
shares
|
$13.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.96%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
4,180,768
shares
|
$12.7 Million
0.33% of portfolio
|
Q3 2021
Reduced 32.82%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Feb 14, 2025 Q4 2024 |
4,105,095
shares
|
$12.4 Million
0.18% of portfolio
|
Q2 2023
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,803,477
shares
|
$11.5 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.49%
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,257,311
shares
|
$9.87 Million
0.02% of portfolio
|
Q4 2024
Added 28.56%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,608,400
shares
|
$7.9 Million
0.02% of portfolio
|
Q4 2024
Added 19.78%
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
2,582,816
shares
|
$7.83 Million
0.57% of portfolio
|
Q4 2024
Added 12.3%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,486,893
shares
|
$7.54 Million
0.01% of portfolio
|
Q4 2024
Reduced 15.6%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,975,348
shares
|
$5.99 Million
0.0% of portfolio
|
Q4 2024
Added 8984.15%
|
|
Guardian Partners Inc.
Toronto, Z4 |
Feb 11, 2025 Q4 2024 |
1,786,414
shares
|
$5.41 Million
0.55% of portfolio
|
Q4 2024
New holding
|
|
Guardian Capital Advisors LP
Toronto, A6 |
Nov 12, 2024 Q3 2024 |
1,786,414
shares
|
$5.41 Million
0.48% of portfolio
|
Q4 2022
Reduced 52.19%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,482,715
shares
|
$4.49 Million
0.0% of portfolio
|
Q4 2024
Added 96.68%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
1,284,533
shares
|
$3.89 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Novo Holdings
Hellerup, G7 |
Feb 14, 2025 Q4 2024 |
1,126,915
shares
|
$3.41 Million
0.27% of portfolio
|
Q2 2022
New holding
|
|
Opaleye Management Inc.
Boston, MA |
Feb 14, 2025 Q4 2024 |
965,000
shares
|
$2.92 Million
0.56% of portfolio
|
Q4 2024
Added 20.63%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
937,385
shares
|
$2.84 Million
0.0% of portfolio
|
Q4 2024
Added 58.97%
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
928,594
shares
|
$2.81 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.32%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
916,237
shares
|
$2.78 Million
0.01% of portfolio
|
Q4 2024
Reduced 59.86%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
597,251
shares
|
$1.81 Million
0.0% of portfolio
|
Q4 2024
Reduced 60.17%
|